Zobrazeno 1 - 10
of 442
pro vyhledávání: ''
Autor:
Ines Beilmann-Lehtonen, Ulf-Håkan Stenman, Caj Haglund, Tuomas Kaprio, Kajsa Björkman, Camilla Böckelman
Publikováno v:
Oncology. 100:22-30
Objectives: Colorectal cancer is the third most common cancer worldwide, with an obvious need for more accurate prognostics. Previous studies identified C-reactive protein (CRP) as a prognostic serum biomarker for colorectal cancer, whereas the bioma
Autor:
Gi-Ming Wang, Kristen Waite, Nakayama John, Jill S. Barnholtz-Sloan, Nirav Patil, Gino Cioffi, Ravi Kumar Kyasaram, John Shanahan, Paolo Caimi
Publikováno v:
ONCOLOGY. :462-470
Objectives: COVID-19 created unexpected delays in oncologic treatment. This study sought to assess the volume of missed cancer-related services due to the pandemic. Methods: This case-controlled trial evaluated more than 345,000 oncologic clinic, lab
Autor:
Mehmet Sitki Copur, Thomas Zusag, Nicholas Lintel, John Allen, Wendel Whitney, Paul Rodriguez, Scott Bell
Publikováno v:
ONCOLOGY. :128-133
Spinal cord compression is a potentially devastating consequence of cancer. Early recognition of the signs and symptoms permit diagnosis prior to the development of irreversible neurological damage. This complication occurs in 5% to 10% of patients w
Publikováno v:
ONCOLOGY. :111-118
Background With fewer than 7% of patients with small cell lung cancer (SCLC) surviving 5 years after diagnosis, the receipt of recommended treatment is of utmost importance for patient survival. Nevertheless, treatment refusal by patients with SCLC h
Autor:
Alla Berlin, Leora Brazg Ferro, Ester Osher, Orit Gutfeld, Inbal Golomb, Inna Ospovat, Viacheslav Soyfer, Ido Wolf, Shira Peleg Hasson
Publikováno v:
Oncology. 99:373-379
Introduction: Extrapulmonary small-cell cancer (EPSCC) is a relatively rare malignancy. The management of EPSCC is usually extrapolated from small-cell lung cancer (SCLC). In spite of the morphological similarity of the 2 malignancies, there are many
Autor:
Brian D. Badgwell, Catherine E Devine, Yang Lu, Jane E. Rogers, Ahmed Abdelhakeem, Allison Trail, Naruhiko Ikoma, Tara Sagebiel, Xuemei Wang, Jeannelyn S. Estrella, Madhavi Patnana, Jaffer A. Ajani, Mariela A. Blum Murphy
Publikováno v:
Oncology. 99:659-664
Background: The value of baseline fluorodeoxyglucose-positron emission tomography-computed tomography (PET-CT) remains uncertain once gastroesophageal cancer is metastatic. We hypothesized that assessment of detailed PET-CT parameters (maximum standa
Publikováno v:
Oncology. 99:260-270
Objective: Prostate and skin cancer are among the most prevalent forms of cancer among men and have favorable survival rates compared to other, more aggressive forms of cancers. Recent studies have shown that the odds of depression among men with a l
Autor:
Young Suk Park, Jeeyun Lee, Hyera Kim, Seonggyu Byeon, Jung Yong Hong, Se Hoon Park, Kee-Taek Jang, Won Ki Kang, Joon Oh Park, Seung Tae Kim, Ho Yeong Lim, Jinchul Kim
Publikováno v:
Oncology. 99:365-372
Background: Biliary tract cancer (BTC) is associated with poor prognosis because of its aggressive and heterogeneous nature. Programmed death ligand 1 (PD-L1) has been considered a novel biomarker for prognosis and response of immune checkpoint inhib
Autor:
Brittney S Zimmerman, Krystal Pauline Cascetta, Amy Tiersten, Erin Moshier, Meng Ru, Danielle Seidman
Publikováno v:
Oncology. 99:280-291
Introduction: The aim of this study was to assess for clinicopathologic and socioeconomic features that predict improved survival for patients with advanced breast cancer with synchronous brain metastases at diagnosis. Methods: We utilized the Nation
Autor:
Sture Löfgren, Bengt-Åke Andersson, Mats Nilsson, Freddi Lewin, Nongnit Laytragoon Lewin, Delmy Oliva
Publikováno v:
Oncology
Introduction: It has been suggested that age could influence the treatment-induced side effects and survival time of cancer patients. The influence of age on blood-based biomarkers, acute radiation skin reactions (ARSRs), and survival time of breast